The Effect of Soursop Supplementation on Blood Pressure, Serum Uric Acid and Kidney Function in Prehypertensive Patients
NCT ID: NCT03531203
Last Updated: 2018-05-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
143 participants
INTERVENTIONAL
2017-07-10
2018-01-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The definition of prehypertension and hypertension was accepted as delivered in The Seventh Report of the Joint National Committee (JNC 7) as the systolic BP was 120 - 139 mmHg and diastolic BP was 80 - 89 mmHg for prehypertension, while systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg for hypertension.
Based on the study by Sja'bani (2014), the cut-off point of (SUA) was divided into 3 categories, which are normal (\< 5 mg/dL), high-normal (5 - \<7 mg/dL), and high (≥ 7 mg/dL).
A number of 143 people with essential prehypertension and high normal uric acid level were assigned as subject in this study. Subjects were randomly assigned into two groups which are treatment and control group. For a 3 months period, the treatment group was given 2x100 g soursop fruit juice per day and the control group was left without treatment.
Blood pressure was measured by medical team using Omron HEM-907 (digital automatic blood pressure monitoring) every 2 weeks (3 times readings for each) in each subject's home. Subjects were examined in sitting position. Evaluation of laboratory examination was taken at week 0, 7 and 13.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation of the Atherogenic Effects of Uric Acid-modified in Endothelial Dysfunction and the the Preventional Mechanism by Anthocyanidines
NCT02797028
Center of Research Translation (CORT) Project 2
NCT02038179
Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure
NCT01472692
The Diet Gout Trial
NCT03569020
Effect of Prebiotics on Hyperuricemia
NCT05385003
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
With Soursop
Treatment group (with soursop group) was a group which receive soursop supplementation
Soursop supplementation
The soursop supplementation was given to treatment group (with soursop group) 2 times a day for 100 g each for 3 months period.
Without Soursop
Control group (without soursop group) was a group which do not receive any intervention (placebo)
Placebo
Control group (without soursop group) was left without treatment during study period
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Soursop supplementation
The soursop supplementation was given to treatment group (with soursop group) 2 times a day for 100 g each for 3 months period.
Placebo
Control group (without soursop group) was left without treatment during study period
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. male or female resident in Mlati, Sleman with or without family history of hypertension,
3. age 30-59 years,
4. high normal uric acid levels (≥ 5 and \< 7 mg/dL) and
5. agreed to follow the study by giving their informed consent.
Exclusion Criteria
2. using hormonal contraceptive,
3. in pregnancy,
4. taking uric acid-lowering drugs (allopurinol, probenecid),
5. positive urine reduction, positive proteinuria, creatinine \> 1.5 g/dL, Blood Glucose \> 126 g/dL.
30 Years
59 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mlati Study Group, Faculty of Medicine, Gadjah Mada University
UNKNOWN
Gadjah Mada University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mochammad Sja'bani
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mochammad Sja'bani, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Internal Medicine, Faculty of Medicine, University of Gadjah Mada
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mlati 2 Health Center working area (Sumberadi, Tlogoadi,Tirtoadi)
Sleman, Special Region of Yogyakarta, Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Soursop Supplementation 2017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.